radiomers

N/A

Report date: 2025/06/11 10:38:50
NME

Base Information

Drug Nameradiomers
Drug Alias Nameraptamer-targeted radiopharmaceuticals/radioligand therapy (Champions Oncology/Fannin)
ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFannin Partners LLC (d/b/a Fannin Innovation Studio)
China Registration ClassN/A

Develop Information

Active CompaniesFannin Partners LLC (d/b/a Fannin Innovation Studio)Champions Oncology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A